Citations (140)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Amirhossein Sahebkar, Luis E. Simental-Mendía, Matteo Pirro, Fabrizio Montecucco, Federico Carbone, Maciej Banach, George E. Barreto & Alexandra E. Butler. (2018) Impact of fibrates on circulating cystatin C levels: a systematic review and meta-analysis of clinical trials. Annals of Medicine 50:6, pages 485-493.
Read now
Read now
Michael Leutner, Christian Göbl, Oliver Schlager, Silvia Charwat-Resl, Alice Wielandner, Eleonora Howorka, Marlies Prünner, Latife Bozkurt, Katharina Maruszczak, Hacer Geyik, Helmut Prosch, Giovanni Pacini & Alexandra Kautzky-Willer. (2017) The Fatty Liver Index (FLI) Relates to Diabetes-Specific Parameters and an Adverse Lipid Profile in a Cohort of Nondiabetic, Dyslipidemic Patients. Journal of the American College of Nutrition 36:4, pages 287-294.
Read now
Read now
Amirhossein Sahebkar. (2017) Effects of quercetin supplementation on lipid profile: A systematic review and meta-analysis of randomized controlled trials. Critical Reviews in Food Science and Nutrition 57:4, pages 666-676.
Read now
Read now
Paola Dongiovanni, Raffaela Rametta, Marica Meroni & Luca Valenti. (2016) The role of insulin resistance in nonalcoholic steatohepatitis and liver disease development – a potential therapeutic target?. Expert Review of Gastroenterology & Hepatology 10:2, pages 229-242.
Read now
Read now
Zhong-Min Liu, Miao Hu, Paul Chan & Brian Tomlinson. (2015) Early investigational drugs targeting PPAR-α for the treatment of metabolic disease. Expert Opinion on Investigational Drugs 24:5, pages 611-621.
Read now
Read now
Anthony S Wierzbicki & Adie Viljoen. (2014) Fibrates and niacin: is there a place for them in clinical practice?. Expert Opinion on Pharmacotherapy 15:18, pages 2673-2680.
Read now
Read now
Manfredi Rizzo, Giuseppe Montalto & Khalid Al-Rasadi. (2014) Treatment options for managing atherogenic dyslipidemia and fatty liver disease. Expert Opinion on Pharmacotherapy 15:8, pages 1065-1068.
Read now
Read now
Articles from other publishers (133)
Jian Wu. (2016) Utilization of animal models to investigate nonalcoholic steatohepatitis-associated hepatocellular carcinoma. Oncotarget 7:27, pages 42762-42776.
Crossref
Crossref
Santo Colosimo, Sandip Kumar Mitra, Tirthankar Chaudhury & Giulio Marchesini. (2023) Insulin resistance and metabolic flexibility as drivers of liver and cardiac disease in T2DM. Diabetes Research and Clinical Practice 206, pages 111016.
Crossref
Crossref
Fateme Ziamanesh, Mehdi Mohammadi, Sholeh Ebrahimpour, Ozra Tabatabaei-Malazy, Asieh Mosallanejad & Bagher Larijani. (2023) Unraveling the link between insulin resistance and Non-alcoholic fatty liver disease (or metabolic dysfunction-associated steatotic liver disease): A Narrative Review. Journal of Diabetes & Metabolic Disorders 22:2, pages 1083-1094.
Crossref
Crossref
Shima Dowla Anwar, Christy Foster & Ambika Ashraf. (2023) Lipid Disorders and Metabolic-Associated Fatty Liver Disease. Endocrinology and Metabolism Clinics of North America 52:3, pages 445-457.
Crossref
Crossref
Ju-Hyeon Bae, Areum Jo, Sung Chun Cho, Yun-Il Lee, Tae-In Kam, Chang-Lim You, Hyeon-Ju Jeong, Hyebeen Kim, Myong-Ho Jeong, Yideul Jeong, Young Wan Ha, Yu Seon Kim, Jiwoon KimSeung-Hwa Woo, Minseok S. Kim, Eui Seok ShinSang Ok Song, Hojin KangRin Khang, Soojeong Park, Joobae Park, Valina L. Dawson, Ted M. Dawson, Sang Chul Park, Joo-Ho Shin & Jong-Sun Kang. (2023) Farnesol prevents aging-related muscle weakness in mice through enhanced farnesylation of Parkin-interacting substrate. Science Translational Medicine 15:711.
Crossref
Crossref
Yuta Taniuchi, J. W. Olivier van Till, Tomasz Wojtkowski, Junko Toyoshima, Akira Koibuchi, Briana Sargent & David Han. (2023) Single‐ and Multiple‐dose Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASP1128, a Novel Peroxisome Proliferator‐activated Receptor δ Modulator, in Healthy Participants. Clinical Pharmacology in Drug Development 12:8, pages 810-818.
Crossref
Crossref
J.W. Olivier van Till, Hiroyuki Nojima, Chisato Kameoka, Chieri Hayashi, Taishi Sakatani, T. Benton Washburn, Bruce A. Molitoris, Andrew D. Shaw, Daniel T. Engelman & John A. Kellum. (2023) The Effects of Peroxisome Proliferator-Activated Receptor-Delta Modulator ASP1128 in Patients at Risk for Acute Kidney Injury Following Cardiac Surgery. Kidney International Reports 8:7, pages 1407-1416.
Crossref
Crossref
D. V. Minin, S. V. Popkov, K. V. Pesochinskaya & D. R. Aleksanov. (2023) Synthesis of [4-(3-aryl-1,2,4-oxadiazol-5-ylmethylthio)-2-methylphenoxy]acetic acids as new potential PPAR agonists. Russian Chemical Bulletin 72:7, pages 1648-1653.
Crossref
Crossref
Jung Yoon Jang, Donghwan Kim & Nam Deuk Kim. (2023) Pathogenesis, Intervention, and Current Status of Drug Development for Sarcopenia: A Review. Biomedicines 11:6, pages 1635.
Crossref
Crossref
Yanqiu Zhang, Shengtao Ye, Weijia Lu, Jiawen Zhong, Yingrong Leng, Ting Yang, Jun Luo, Wenjun Xu, Hao Zhang & Lingyi Kong. (2023) RNA helicase DEAD‐box protein 5 alleviates nonalcoholic steatohepatitis progression via tethering TSC complex and suppressing mTORC1 signaling. Hepatology 77:5, pages 1670-1687.
Crossref
Crossref
Young Eum Hyun, Seungchan An, Minjae Kim, In Guk Park, Sanghee Yoon, Hafiz Muhammad Ahmad Javaid, Thi Ngoc Lan Vu, Gyudong Kim, Hongseok Choi, Hyuk Woo Lee, Minsoo Noh, Joo Young Huh, Sun Choi, Hong-Rae Kim & Lak Shin Jeong. (2023) Structure–Activity Relationships of Truncated 1′-Homologated Carbaadenosine Derivatives as New PPARγ/δ Ligands: A Study on Sugar Puckering Affecting Binding to PPARs. Journal of Medicinal Chemistry 66:7, pages 4961-4978.
Crossref
Crossref
Lisa-Marie Burkhardt, Christian H. Bucher, Julia Löffler, Charlotte Rinne, Georg N. Duda, Sven Geissler, Tim J. Schulz & Katharina Schmidt-Bleek. (2023) The benefits of adipocyte metabolism in bone health and regeneration. Frontiers in Cell and Developmental Biology 11.
Crossref
Crossref
Nicole Wagner & Kay-Dietrich Wagner. (2023) Pharmacological Utility of PPAR Modulation for Angiogenesis in Cardiovascular Disease. International Journal of Molecular Sciences 24:3, pages 2345.
Crossref
Crossref
Jaekyeong Kim, Hyejin Ko, Jae-Seoun Hur, Seungchan An, Jin Woo Lee, Stephen T. Deyrup, Minsoo Noh & Sang Hee Shim. (2022)
Discovery of Pan-peroxisome Proliferator-Activated Receptor Modulators from an Endolichenic Fungus,
Daldinia childiae
. Journal of Natural Products 85:12, pages 2804-2816.
Crossref
Crossref
Mohamed Magdy Aly Hassan ElMeligie. 2022. Exercise Physiology. Exercise Physiology.
Mohammed Eslam, Hashem B. El-Serag, Sven Francque, Shiv K. Sarin, Lai Wei, Elisabetta Bugianesi & Jacob George. (2022) Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight. Nature Reviews Gastroenterology & Hepatology 19:10, pages 638-651.
Crossref
Crossref
Xu Huang, Yang Zhang, Weiwei Zhang, Cheng Qin, Yan Zhu, Yan Fang, Yabin Wang, Chengchun Tang & Feng Cao. (2022)
Osteopontin-Targeted and PPARδ-Agonist-Loaded Nanoparticles Efficiently Reduce Atherosclerosis in Apolipoprotein E
–/–
Mice
. ACS Omega 7:33, pages 28767-28778.
Crossref
Crossref
Piotr Przybycień, Danuta Gąsior-Perczak & Wojciech Placha. (2022) Cannabinoids and PPAR Ligands: The Future in Treatment of Polycystic Ovary Syndrome Women with Obesity and Reduced Fertility. Cells 11:16, pages 2569.
Crossref
Crossref
Shimaa A. Sadek, Asmaa E. Farouk, Sohair R. Fahmy & Amel M. Soliman. (2022) Holothuria arenicola Extract Attenuated Hepatic Steatosis in Splenectomized
Rat Fed High Fat Diet. The Natural Products Journal 12:3.
Crossref
Crossref
Gargi Dixit & Arati Prabhu. (2022) The pleiotropic peroxisome proliferator activated receptors: Regulation and therapeutics. Experimental and Molecular Pathology 124, pages 104723.
Crossref
Crossref
Willem Koert, Mariël Zwaagstra, Patricia Nagtegaal, Leendert van der Kooij, Koen Terlouw & Erik Duiven. (2021) SARMs: een nieuw gezondheidsprobleem in fitness en bodybuildingSARMs: an emergent health problem in fitness and bodybuilding. TSG - Tijdschrift voor gezondheidswetenschappen 99:4, pages 161-164.
Crossref
Crossref
Ratih Dewi Yudhani, Dwi Aris Agung Nugrahaningsih, Eti Nurwening Sholikhah & Mustofa Mustofa. (2021) The Molecular Mechanisms of Hypoglycemic Properties and Safety Profiles of Swietenia Macrophylla Seeds Extract: A Review. Open Access Macedonian Journal of Medical Sciences 9:F, pages 370-388.
Crossref
Crossref
Keyhan Mohammadi, Mahmood Alizadeh Sani, Elyas Nattagh‐Eshtivani, Shakila Yaribash, Jamal Rahmani, Behdad Shokrollahi Yancheshmeh & David Julian McClements. (2021) A systematic review and meta‐analysis of the impact of cornelian cherry consumption on blood lipid profiles. Food Science & Nutrition 9:8, pages 4629-4638.
Crossref
Crossref
Stéphane Trevisiol, Yves Moulard, Vivian Delcourt, Murielle Jaubert, Sophie Boyer, Sophie Tendon, Hayate Haryouli, Wafek Taleb, Mylène Caroff, Benjamin Chabot, Laura Drif, François André, Patrice Garcia, Benoit Loup, Marie‐Agnès Popot & Ludovic Bailly‐Chouriberry. (2021) Comprehensive characterization of the peroxisome proliferator activated receptor‐δ agonist GW501516 for horse doping control analysis. Drug Testing and Analysis 13:6, pages 1191-1202.
Crossref
Crossref
Alexandre Berthier, Manuel Johanns, Francesco Paolo Zummo, Philippe Lefebvre & Bart Staels. (2021) PPARs in liver physiology. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1867:5, pages 166097.
Crossref
Crossref
Hideaki Ishii, Mariko Shibuya, Gary Ngai‐Wa Leung, Shozo Yamashita, Masayuki Yamada, Asuka Kushiro, Yoshinori Kasashima, Jun Okada, Kazumi Kawasaki & Isao Kijima‐Suda. (2021) Metabolic study of GW1516 in equine urine using liquid chromatography/electrospray ionization Q‐Exactive high‐resolution mass spectrometry for doping control. Rapid Communications in Mass Spectrometry 35:5.
Crossref
Crossref
Vian Ahmed Wasta Esmail, Mohammed Omer Mohammed & Marwan S.M. Al-Nimer. (2021) Short-term orlistat therapy improves fatty infiltration indices and liver fibrosis scores in patients with non-alcoholic fatty liver disease and metabolic syndrome. Arab Journal of Gastroenterology 22:1, pages 1-5.
Crossref
Crossref
Girolamo Di Maio, Nicola Alessio, Ibrahim Halil Demirsoy, Gianfranco Peluso, Silverio Perrotta, Marcellino Monda & Giovanni Di Bernardo. (2021) Evaluation of Browning Agents on the White Adipogenesis of Bone Marrow Mesenchymal Stromal Cells: A Contribution to Fighting Obesity. Cells 10:2, pages 403.
Crossref
Crossref
Dia Advani, Sudhanshu Sharma, Rahul Tripathi, Rohan Gupta, Asmita Jaiswal, Rashmi K. Ambasta & Pravir Kumar. 2021. Mitochondrial Dysfunction and Nanotherapeutics. Mitochondrial Dysfunction and Nanotherapeutics
91
137
.
Tam Dao, Alexander E. Green, Yun A Kim, Sung-Jin Bae, Ki-Tae Ha, Karim Gariani, Mi-ra Lee, Keir J. Menzies & Dongryeol Ryu. (2020) Sarcopenia and Muscle Aging: A Brief Overview. Endocrinology and Metabolism 35:4, pages 716-732.
Crossref
Crossref
Seungchan An, Gyudong Kim, Hyun Jin Kim, Sungjin Ahn, Hyun Young Kim, Hyejin Ko, Young Eum Hyun, Mai Nguyen, Juri Jeong, Zijing Liu, Jinhe Han, Hongseok Choi, Jinha Yu, Ji Won Kim, Hyuk Woo Lee, Kenneth A. Jacobson, Won Jea Cho, Young-Mi Kim, Keon Wook Kang, Minsoo Noh & Lak Shin Jeong. (2020) Discovery and Structure–Activity Relationships of Novel Template, Truncated 1′-Homologated Adenosine Derivatives as Pure Dual PPARγ/δ Modulators. Journal of Medicinal Chemistry 63:24, pages 16012-16027.
Crossref
Crossref
Hideaki Ishii, Gary Ngai‐Wa Leung, Shozo Yamashita, Masayuki Yamada, Asuka Kushiro, Yoshinori Kasashima, Jun Okada, Kazumi Kawasaki & Isao Kijima‐Suda. (2020) Doping control analysis of GW1516 in equine plasma using liquid chromatography/electrospray ionization Q‐Exactive high‐resolution mass spectrometry. Rapid Communications in Mass Spectrometry 34:23.
Crossref
Crossref
John A Kellum, J W Olivier van Till & George Mulligan. (2020) Targeting acute kidney injury in COVID-19. Nephrology Dialysis Transplantation 35:10, pages 1652-1662.
Crossref
Crossref
Tara Man Kadayat, Aarajana Shrestha, Yong Hyun Jeon, Hongchan An, Jina Kim, Sung Jin Cho & Jungwook Chin. (2020) Targeting Peroxisome Proliferator-Activated Receptor Delta (PPARδ): A Medicinal Chemistry Perspective. Journal of Medicinal Chemistry 63:18, pages 10109-10134.
Crossref
Crossref
Mark Wei Yi Tan, Ming Keat Sng, Hong Sheng Cheng, Zun Siong Low, Benjamin Jia Juin Leong, Damien Chua, Eddie Han Pin Tan, Jeremy Soon Kiat Chan, Yun Sheng Yip, Yin Hao Lee, Mintu Pal, Xiaomeng Wang, Walter Wahli & Nguan Soon Tan. (2020) Deficiency in fibroblast PPARβ/δ reduces nonmelanoma skin cancers in mice. Cell Death & Differentiation 27:9, pages 2668-2680.
Crossref
Crossref
Young Seob Lee, Dae Young Lee, Dong Yeul Kwon & Ok Hwa Kang. (2020) Improvement Effect of Non-alcoholic Fatty Liver Disease by Curcuma longa L. Extract. Korean Journal of Medicinal Crop Science 28:4, pages 276-286.
Crossref
Crossref
Yutaro Tobita, Takeshi Arima, Yuji Nakano, Masaaki Uchiyama, Akira Shimizu & Hiroshi Takahashi. (2020) Peroxisome Proliferator-Activated Receptor Beta/Delta Agonist Suppresses Inflammation and Promotes Neovascularization. International Journal of Molecular Sciences 21:15, pages 5296.
Crossref
Crossref
Yu Yang, Yu Zhao, Wenzhen Li, Yuyao Wu, Xin Wang, Yijie Wang, Tingmei Liu, Tinghong Ye, Yongmei Xie, Zhiqiang Cheng, Jun He, Peng Bai, Yiwen Zhang & Liang Ouyang. (2020) Emerging targets and potential therapeutic agents in non-alcoholic fatty liver disease treatment. European Journal of Medicinal Chemistry 197, pages 112311.
Crossref
Crossref
Nima Motamed, Hossein Ajdarkosh, Maral Ahmadi, Dhayaneethie Perumal, G Hossein Ashrafi, Mehdi Nikkhah, Amir Hossein Faraji, Mansooreh Maadi, Mahmoodreza Khoonsari, Nader Rezaie, Behzad Farahani, Fahimeh Safarnezhad Tameshkel, Mitra Ameli, Mahshid Panahi, Mohammad Hadi Karbalaie Niya & Farhad Zamani. (2020) Non-alcoholic fatty liver disease is not independent risk factor for cardiovascular disease event: A cohort study. World Journal of Hepatology 12:6, pages 323-331.
Crossref
Crossref
Ken-ichi Nakashima, Eiji Yamaguchi, Chihaya Noritake, Yukari Mitsugi, Mayuki Goto, Takao Hirai, Naohito Abe, Eiji Sakai, Masayoshi Oyama, Akichika Itoh & Makoto Inoue. (2020) Discovery and SAR of Natural-Product-Inspired RXR Agonists with Heterodimer Selectivity to PPARδ-RXR. ACS Chemical Biology 15:6, pages 1526-1534.
Crossref
Crossref
Xiao-yan Shi, Jia Yao, Si-min Fan, Pei-pei Hong, Yu-guo Xia & Qiu Chen. (2020) Effects of vitamin D supplementation on serum lipid profile in women with polycystic ovary syndrome. Medicine 99:23, pages e20621.
Crossref
Crossref
Myungsuk Kim, GyHye Yoo, Ahmad Randy, Yang-Ju Son, Chi Rac Hong, Sang Min Kim & Chu Won Nho. (2020) Lemon Balm and Its Constituent, Rosmarinic Acid, Alleviate Liver Damage in an Animal Model of Nonalcoholic Steatohepatitis. Nutrients 12:4, pages 1166.
Crossref
Crossref
Yujie HuangHedong LangKa ChenYong ZhangYanxiang GaoLi RanLong YiMantian MiQianyong Zhang. (2020) Resveratrol protects against nonalcoholic fatty liver disease by improving lipid metabolism and redox homeostasis via the PPARα pathway. Applied Physiology, Nutrition, and Metabolism 45:3, pages 227-239.
Crossref
Crossref
Amila Omeragic, Michael F. Saikali, Sydney Currier, David J. Volsky, Carolyn L. Cummins & Reina Bendayan. (2019) Selective peroxisome proliferator‐activated receptor‐gamma modulator, INT131 exhibits anti‐inflammatory effects in an EcoHIV mouse model. The FASEB Journal 34:2, pages 1996-2010.
Crossref
Crossref
Michael Doumas, Konstantinos Imprialos, Konstantinos Stavropoulos & Vasilios G. Athyros. (2020) Pharmacological Management of Type 2 Diabetes Complications. Current Vascular Pharmacology 18:2, pages 101-103.
Crossref
Crossref
Vasilios G. Athyros, Stergios A. Polyzos, Jiannis Kountouras, Niki Katsiki, Panagiotis Anagnostis, Michael Doumas & Christos S. Mantzoros. (2020) Non-Alcoholic Fatty Liver Disease Treatment in Patients with Type 2 Diabetes Mellitus; New Kids on the Block. Current Vascular Pharmacology 18:2, pages 172-181.
Crossref
Crossref
Ramesh Kumar, Rajeev Nayan Priyadarshi & Utpal Anand. (2019) Non-alcoholic Fatty Liver Disease: Growing Burden, Adverse Outcomes and Associations. Journal of Clinical and Translational Hepatology X:X, pages 1-11.
Crossref
Crossref
Magdalene K. Montgomery, Jacqueline Bayliss, Stacey Keenan, Sarah Rhost, Stephen B. Ting & Matthew J. Watt. (2019) The role of Ap2a2 in PPARα‐mediated regulation of lipolysis in adipose tissue. The FASEB Journal 33:12, pages 13267-13279.
Crossref
Crossref
Cheng, Tan, Low, Marvalim, Lee & Tan. (2019) Exploration and Development of PPAR Modulators in Health and Disease: An Update of Clinical Evidence. International Journal of Molecular Sciences 20:20, pages 5055.
Crossref
Crossref
Eric L. Bell, Robert W. Shine, Peter Dwyer, Lyndsay Olson, Jennifer Truong, Ross Fredenburg, Matthew Goddeeris, Dominique Stickens & Effie Tozzo. (2019) PPARδ modulation rescues mitochondrial fatty acid oxidation defects in the mdx model of muscular dystrophy. Mitochondrion 46, pages 51-58.
Crossref
Crossref
Long Pham Ngoc, Hai-yen Man, Harry Besselink, Ha Dang Thi Cam, Abraham Brouwer & Bart van der Burg. (2019) Identification of PPAR-activating compounds in herbal and edible plants and fungi from Vietnam. Industrial Crops and Products 129, pages 195-200.
Crossref
Crossref
Benny Da’adoosh, David Marcus, Anwar Rayan, Fred King, Jianwei Che & Amiram Goldblum. (2019) Discovering highly selective and diverse PPAR-delta agonists by ligand based machine learning and structural modeling. Scientific Reports 9:1.
Crossref
Crossref
Amir Abbas Momtazi-Borojeni, Seyed Hasan Ayati, Mahmoud Reza Jaafari & Amirhossein Sahebkar. (2019) A simple and rapid-acting approach for the reduction of C-reactive protein. Biomedicine & Pharmacotherapy 109, pages 2305-2308.
Crossref
Crossref
Mohsen Mohammadi-Sartang, Mohammad Ghorbani & Zohreh Mazloom. (2018) Effects of melatonin supplementation on blood lipid concentrations: A systematic review and meta-analysis of randomized controlled trials. Clinical Nutrition 37:6, pages 1943-1954.
Crossref
Crossref
Akshay Shetty, Jennifer W. Hsu, Paul P. Manka & Wing-Kin Syn. (2018) Role of the Circadian Clock in the Metabolic Syndrome and Nonalcoholic Fatty Liver Disease. Digestive Diseases and Sciences 63:12, pages 3187-3206.
Crossref
Crossref
Shiva Ganjali, Antonio M. GottoJr.Jr., Massimiliano Ruscica, Stephen L. Atkin, Alexandra E. Butler, Maciej Banach & Amirhossein Sahebkar. (2018) Monocyte‐to‐HDL‐cholesterol ratio as a prognostic marker in cardiovascular diseases. Journal of Cellular Physiology 233:12, pages 9237-9246.
Crossref
Crossref
Yi Liu, Jennifer Colby, Xiangsheng Zuo, Jonathan Jaoude, Daoyan Wei & Imad Shureiqi. (2018) The Role of PPAR-δ in Metabolism, Inflammation, and Cancer: Many Characters of a Critical Transcription Factor. International Journal of Molecular Sciences 19:11, pages 3339.
Crossref
Crossref
Nadia Bougarne, Basiel Weyers, Sofie J Desmet, Julie Deckers, David W Ray, Bart Staels & Karolien De Bosscher. (2018) Molecular Actions of PPARα in Lipid Metabolism and Inflammation. Endocrine Reviews 39:5, pages 760-802.
Crossref
Crossref
Habib Yaribeygi, Mohammad T. Mohammadi, Ramin Rezaee & Amirhossein Sahebkar. (2018) Fenofibrate improves renal function by amelioration of NOX‐4, IL‐18, and p53 expression in an experimental model of diabetic nephropathy. Journal of Cellular Biochemistry 119:9, pages 7458-7469.
Crossref
Crossref
Yu Yuan Li, Dan Tang, Yan Lei Du, Chuang Yu Cao, Yu Qiang Nie, Jie Cao & Yong Jian Zhou. (2018) Fatty liver mediated by peroxisome proliferator-activated receptor-α DNA methylation can be reversed by a methylation inhibitor and curcumin. Journal of Digestive Diseases 19:7, pages 421-430.
Crossref
Crossref
Amir Hooshang Mohammadpour, Zakieh Salehinejad, Sepideh Elyasi, Mohsen Mouhebati, Seyed Reza Mirhafez, Sara Samadi, Majid Ghayour-Mobarhan, Gordon Ferns & Amirhossein Sahebkar. (2018) Evaluation of serum cathepsin D concentrations in coronary artery disease. Indian Heart Journal 70:4, pages 471-475.
Crossref
Crossref
Clifford J Bailey & Caroline Day. (2018) Treatment of type 2 diabetes: future approaches. British Medical Bulletin 126:1, pages 123-137.
Crossref
Crossref
Margherita Botta, Matteo Audano, Amirhossein Sahebkar, Cesare Sirtori, Nico Mitro & Massimiliano Ruscica. (2018) PPAR Agonists and Metabolic Syndrome: An Established Role?. International Journal of Molecular Sciences 19:4, pages 1197.
Crossref
Crossref
V. A. Kudinov, T. S. Zakharova, T. I. Torkhovskaya, O. M. Ipatova & A. I. Archakov. (2018) Pharmacological Targets for Correction of Dyslipidemias. Opportunities and Prospects of Therapeutic Use. Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry 12:2, pages 96-113.
Crossref
Crossref
Farshad Amirkhizi, Soudabeh Hamedi-Shahraki, Sonya Hosseinpour-Arjmand & Mehrangiz Ebrahimi-Mameghani. (2018) The Effect of Alpha-Lipoic Acid on Liver Function and Metabolic Markers in Obese Patients with Non-Alcoholic Fatty Liver Disease: A Double - Blind Randomized Controlled Trial. Iranian Red Crescent Medical Journal 20:3.
Crossref
Crossref
Tapan Dave, Arno William Tilles & Muralikrishna Vemula. (2018) A Cell-Based Assay to Investigate Hypolipidemic Effects of Nonalcoholic Fatty Liver Disease Therapeutics. SLAS Discovery 23:3, pages 274-282.
Crossref
Crossref
Myong-Min Lee, Hyeong-Geug Kim, Sung-Bae Lee, Jin-Seok Lee, Won-Yong Kim, Seung-Hoon Choi, Sam-Keun Lee, Chang-Kyu Byun, Pung-Mi Hyun & Chang-Gue Son. (2018) CGplus, a standardized herbal composition ameliorates non-alcoholic steatohepatitis in a tunicamycin-induced mouse model. Phytomedicine 41, pages 24-32.
Crossref
Crossref
Yan Jia, Yao Gan, Congfen He, Zhou Chen & Cheng Zhou. (2018) The mechanism of skin lipids influencing skin status. Journal of Dermatological Science 89:2, pages 112-119.
Crossref
Crossref
V.A. Kudinov, T.S. Zakharova, T.I. Torkhovskaya, O.M. Ipatova & A.I. Archakov. (2018) Pharmacological targets for dislipidemies correction. Opportunities and prospects of therapeutic usage. Biomeditsinskaya Khimiya 64:1, pages 66-83.
Crossref
Crossref
Martin Weihrauch & Christoph Handschin. (2018) Pharmacological targeting of exercise adaptations in skeletal muscle: Benefits and pitfalls. Biochemical Pharmacology 147, pages 211-220.
Crossref
Crossref
Amirhossein Sahebkar, Luis E. Simental-Mendía, Gerald F. Watts, Maria-Corina Serban & Maciej Banach. (2017) Comparison of the effects of fibrates versus statins on plasma lipoprotein(a) concentrations: a systematic review and meta-analysis of head-to-head randomized controlled trials. BMC Medicine 15:1.
Crossref
Crossref
Xiao-Feng Li, Ying-Yin Sun, Jing Bao, Xin Chen, Yu-Huan Li, Yang Yang, Lei Zhang, Cheng Huang, Bao-Ming Wu, Xiao-Ming Meng & Jun Li. (2017) Functional role of PPAR-γ on the proliferation and migration of fibroblast-like synoviocytes in rheumatoid arthritis. Scientific Reports 7:1.
Crossref
Crossref
Fahrettin Haczeyni, Hans Wang, Vanessa Barn, Auvro R. Mridha, Matthew M. Yeh, W. Geoffrey Haigh, George N. Ioannou, Yun‐Jung Choi, Charles A. McWherter, Narcissus C.‐H. Teoh & Geoffrey C. Farrell. (2017) The selective peroxisome proliferator–activated receptor‐delta agonist seladelpar reverses nonalcoholic steatohepatitis pathology by abrogating lipotoxicity in diabetic obese mice. Hepatology Communications 1:7, pages 663-674.
Crossref
Crossref
Lulu Wang, Susu Wu, Minxuan Cai, Ji Ma, Shengcun Li, Maoru Li, Yan Xu, Lixin Wei & Jing Shang. (2017) Comprehensive Study of Multiple Stages Progressing to Nonalcoholic Steatohepatitis with Subsequent Fibrosis in SD Rats. International Journal of Molecular Sciences 18:8, pages 1681.
Crossref
Crossref
Ajit Magadum, Yishu Ding, Lan He, Teayoun Kim, Mohankrishna Dalvoy Vasudevarao, Qinqiang Long, Kevin Yang, Nadeera Wickramasinghe, Harsha V Renikunta, Nicole Dubois, Gilbert Weidinger, Qinglin Yang & Felix B Engel. (2017) Live cell screening platform identifies PPARδ as a regulator of cardiomyocyte proliferation and cardiac repair. Cell Research 27:8, pages 1002-1019.
Crossref
Crossref
Amirhossein Sahebkar, Luis E. Simental-Mendía, Željko Reiner, Petri T. Kovanen, Mario Simental-Mendía, Vanessa Bianconi & Matteo Pirro. (2017) Effect of orlistat on plasma lipids and body weight: A systematic review and meta-analysis of 33 randomized controlled trials. Pharmacological Research 122, pages 53-65.
Crossref
Crossref
Chang Feng, Dandan Li, Liping Jiang, Xiaofang Liu, Qiujuan Li, Chengyan Geng, Xiance Sun, Guang Yang, Xiaofeng Yao & Min Chen. (2017) Citreoviridin induces triglyceride accumulation in hepatocytes through inhibiting PPAR-α in vivo and in vitro. Chemico-Biological Interactions 273, pages 212-218.
Crossref
Crossref
Vasilios G. Athyros, Theodore K. Alexandrides, Helen Bilianou, Evangelos Cholongitas, Michael Doumas, Emmanuel S. Ganotakis, John Goudevenos, Moses S. Elisaf, Georgios Germanidis, Olga Giouleme, Asterios Karagiannis, Charalambos Karvounis, Niki Katsiki, Vasilios Kotsis, Jannis Kountouras, Evangelos Liberopoulos, Christos Pitsavos, Stergios Polyzos, Loukianos S. Rallidis, Dimitrios Richter, Apostolos G. Tsapas, Alexandros D. Tselepis, Konstantinos Tsioufis, Konstantinos Tziomalos, Themistoklis Tzotzas, Themistoklis G. Vasiliadis, Charalambos Vlachopoulos, Dimitri P. Mikhailidis & Christos Mantzoros. (2017) The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement. Metabolism 71, pages 17-32.
Crossref
Crossref
Lu Han, Wen-Jun Shen, Stefanie Bittner, Fredric B Kraemer & Salman Azhar. (2017) PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part II: PPAR-β/δ and PPAR-γ. Future Cardiology 13:3, pages 279-296.
Crossref
Crossref
Lu Han, Wen-Jun Shen, Stefanie Bittner, Fredric B Kraemer & Salman Azhar. (2017) PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part I: PPAR-α. Future Cardiology 13:3, pages 259-278.
Crossref
Crossref
Na-Na Duan, Xue-Jing Liu & Jian Wu. (2017) Palmitic acid elicits hepatic stellate cell activation through inflammasomes and hedgehog signaling. Life Sciences 176, pages 42-53.
Crossref
Crossref
Bret H. Goodpaster & Lauren M. Sparks. (2017) Metabolic Flexibility in Health and Disease. Cell Metabolism 25:5, pages 1027-1036.
Crossref
Crossref
Kim H.H. Liss & Brian N. Finck. (2017) PPARs and nonalcoholic fatty liver disease. Biochimie 136, pages 65-74.
Crossref
Crossref
José Iglesias, Ludis Morales & George E. Barreto. (2016) Metabolic and Inflammatory Adaptation of Reactive Astrocytes: Role of PPARs. Molecular Neurobiology 54:4, pages 2518-2538.
Crossref
Crossref
Luis E. Simental-Mendía, Mario Simental-Mendía, Amirhossein Sahebkar, Martha Rodríguez-Morán & Fernando Guerrero-Romero. (2017) Effect of magnesium supplementation on lipid profile: a systematic review and meta-analysis of randomized controlled trials. European Journal of Clinical Pharmacology 73:5, pages 525-536.
Crossref
Crossref
Myungsuk Kim, GyHye Yoo, Ahmad Randy, Hyoung Seok Kim & Chu Won Nho. (2017) Chicoric acid attenuate a nonalcoholic steatohepatitis by inhibiting key regulators of lipid metabolism, fibrosis, oxidation, and inflammation in mice with methionine and choline deficiency. Molecular Nutrition & Food Research 61:5, pages 1600632.
Crossref
Crossref
Vanessa Dubois, Jérôme Eeckhoute, Philippe Lefebvre & Bart Staels. (2017) Distinct but complementary contributions of PPAR isotypes to energy homeostasis. Journal of Clinical Investigation 127:4, pages 1202-1214.
Crossref
Crossref
Gianna Ferretti, Tiziana Bacchetti, Luis E. Simental-Mendía, Željko Reiner, Maciej Banach & Amirhossein Sahebkar. (2017) Raloxifene Lowers Plasma Lipoprotein(a) Concentrations: a Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials. Cardiovascular Drugs and Therapy 31:2, pages 197-208.
Crossref
Crossref
Davide Guerrieri, Hyo Youl Moon & Henriette van Praag. (2017) Exercise in a Pill: The Latest on Exercise-Mimetics. Brain Plasticity 2:2, pages 153-169.
Crossref
Crossref
Weiwei Fan & Ronald M. Evans. (2017) Exercise Mimetics: Impact on Health and Performance. Cell Metabolism 25:2, pages 242-247.
Crossref
Crossref
Austin Chan, Keyur Patel & Susanna Naggie. (2017) Genotype 3 Infection: The Last Stand of Hepatitis C Virus. Drugs 77:2, pages 131-144.
Crossref
Crossref
Amirhossein Sahebkar, Nikou Saboni, Matteo Pirro & Maciej Banach. (2017) Curcumin: An effective adjunct in patients with statin-associated muscle symptoms?. Journal of Cachexia, Sarcopenia and Muscle 8:1, pages 19-24.
Crossref
Crossref
Clifford J. Bailey. 2017. Textbook of Diabetes. Textbook of Diabetes
1000
1011
.
Jae Ho Choi, Sun Woo Jin, Chul Yung Choi, Hyung Gyun Kim, Gi Ho Lee, Yong An Kim, Young Chul Chung & Hye Gwang Jeong. (2017) Capsaicin Inhibits Dimethylnitrosamine-Induced Hepatic Fibrosis by Inhibiting the TGF-β1/Smad Pathway via Peroxisome Proliferator-Activated Receptor Gamma Activation. Journal of Agricultural and Food Chemistry 65:2, pages 317-326.
Crossref
Crossref
Richard T. Jaspers, M. Carola Zillikens, Edith C. H. Friesema, Giuseppe Paoli, Wilhelm Bloch, André G. Uitterlinden, Fernando Goglia, Antonia Lanni & Pieter Lange. (2016) Exercise, fasting, and mimetics: toward beneficial combinations?. The FASEB Journal 31:1, pages 14-28.
Crossref
Crossref
Romeo Papazyan, Zheng Sun, Yong Hoon Kim, Paul M. Titchenell, David A. Hill, Wenyun Lu, Manashree Damle, Min Wan, Yuxiang Zhang, Erika R. Briggs, Joshua D. Rabinowitz & Mitchell A. Lazar. (2016) Physiological Suppression of Lipotoxic Liver Damage by Complementary Actions of HDAC3 and SCAP/SREBP. Cell Metabolism 24:6, pages 863-874.
Crossref
Crossref
Amirhossein Sahebkar, Maria-Corina Serban, Anna Gluba-Brzózka, Dimitri P. Mikhailidis, Arrigo F. Cicero, Jacek Rysz & Maciej Banach. (2016) Lipid-modifying effects of nutraceuticals: An evidence-based approach. Nutrition 32:11-12, pages 1179-1192.
Crossref
Crossref
Tsuyoshi Chiba, Sachina Suzuki, Yoko Sato, Tatsuki Itoh & Keizo Umegaki. (2016) Evaluation of Methionine Content in a High-Fat and Choline-Deficient Diet on Body Weight Gain and the Development of Non-Alcoholic Steatohepatitis in Mice. PLOS ONE 11:10, pages e0164191.
Crossref
Crossref
Amirhossein Sahebkar, Renato Giua, Claudio Pedone, Kausik K. Ray, Antonio J. Vallejo-Vaz & Luisa Costanzo. (2016) Fibrate therapy and flow-mediated dilation: A systematic review and meta-analysis of randomized placebo-controlled trials. Pharmacological Research 111, pages 163-179.
Crossref
Crossref
Sander Lefere, Christophe Van Steenkiste, Xavier Verhelst, Hans Van Vlierberghe, Lindsey Devisscher & Anja Geerts. (2016) Hypoxia-regulated mechanisms in the pathogenesis of obesity and non-alcoholic fatty liver disease. Cellular and Molecular Life Sciences 73:18, pages 3419-3431.
Crossref
Crossref
Alexandra Montagner, Arnaud Polizzi, Edwin Fouché, Simon Ducheix, Yannick Lippi, Frédéric Lasserre, Valentin Barquissau, Marion Régnier, Céline Lukowicz, Fadila Benhamed, Alison Iroz, Justine Bertrand-Michel, Talal Al Saati, Patricia Cano, Laila Mselli-Lakhal, Gilles Mithieux, Fabienne Rajas, Sandrine Lagarrigue, Thierry Pineau, Nicolas Loiseau, Catherine Postic, Dominique Langin, Walter Wahli & Hervé Guillou. (2016) Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD. Gut 65:7, pages 1202-1214.
Crossref
Crossref
Thekkuttuparambil Ananthanarayanan Ajith & Thankamani Gopinathan Jayakumar. (2016) Peroxisome proliferator-activated receptors in cardiac energy metabolism and cardiovascular disease. Clinical and Experimental Pharmacology and Physiology 43:7, pages 649-658.
Crossref
Crossref
Amirhossein Sahebkar, Ivan Pećin, Eugenia Tedeschi-Reiner, Giuseppe Derosa, Pamela Maffioli & Željko Reiner. (2016) Effects of statin therapy on augmentation index as a measure of arterial stiffness: A systematic review and meta-analysis. International Journal of Cardiology 212, pages 160-168.
Crossref
Crossref
Giuseppe Derosa, Pamela Maffioli & Amirhossein Sahebkar. (2016) Improvement of plasma adiponectin, leptin and C-reactive protein concentrations by orlistat: a systematic review and meta-analysis. British Journal of Clinical Pharmacology 81:5, pages 819-834.
Crossref
Crossref
Amirhossein Sahebkar, Luis E. Simental-Mendía, Claudio Pedone, Gianna Ferretti, Petr Nachtigal, Simona Bo, Giuseppe Derosa, Pamela Maffioli & Gerald F. Watts. (2016) Statin therapy and plasma free fatty acids: a systematic review and meta-analysis of controlled clinical trials. British Journal of Clinical Pharmacology 81:5, pages 807-818.
Crossref
Crossref
Manuel Vázquez-Carrera. (2016) Unraveling the Effects of PPARβ/δ on Insulin Resistance and Cardiovascular Disease. Trends in Endocrinology & Metabolism 27:5, pages 319-334.
Crossref
Crossref
Amirhossein Sahebkar, Anna Hernández-Aguilera, David Abelló, Elena Sancho, Jordi Camps & Jorge Joven. (2016) Systematic review and meta-analysis deciphering the impact of fibrates on paraoxonase-1 status. Metabolism 65:5, pages 609-622.
Crossref
Crossref
Amirhossein Sahebkar, Guglielmo Beccuti, Luis E. Simental-Mendía, Valerio Nobili & Simona Bo. (2016) Nigella sativa (black seed) effects on plasma lipid concentrations in humans: A systematic review and meta-analysis of randomized placebo-controlled trials. Pharmacological Research 106, pages 37-50.
Crossref
Crossref
Clifford J Bailey, Abd A Tahrani & Anthony H Barnett. (2016) Future glucose-lowering drugs for type 2 diabetes. The Lancet Diabetes & Endocrinology 4:4, pages 350-359.
Crossref
Crossref
Loek P. Smits, Bram F. Coolen, Maria D. Panno, Jurgen H. Runge, Wouter H. Nijhof, Joanne Verheij, Max Nieuwdorp, Jaap Stoker, Ulrich H. Beuers, Aart J. Nederveen & Erik S. Stroes. (2016) Noninvasive Differentiation between Hepatic Steatosis and Steatohepatitis with MR Imaging Enhanced with USPIOs in Patients with Nonalcoholic Fatty Liver Disease: A Proof-of-Concept Study. Radiology 278:3, pages 782-791.
Crossref
Crossref
Amirhossein Sahebkar, Luis E. Simental-Mendía, Claudia Stefanutti & Matteo Pirro. (2016) Supplementation with coenzyme Q10 reduces plasma lipoprotein(a) concentrations but not other lipid indices: A systematic review and meta-analysis. Pharmacological Research 105, pages 198-209.
Crossref
Crossref
Zhiguo Zhang, Bo Li, Xiangjian Meng, Shuangshuang Yao, Lina Jin, Jian Yang, Jiqiu Wang, Huizhi Zhang, Zhijian Zhang, Dongsheng Cai, Yifei Zhang & Guang Ning. (2016) Berberine prevents progression from hepatic steatosis to steatohepatitis and fibrosis by reducing endoplasmic reticulum stress. Scientific Reports 6:1.
Crossref
Crossref
Eleftheria Barlaka, Eleftheria Galatou, Kyriakos Mellidis, Tanya Ravingerova & Antigone Lazou. (2016) Role of Pleiotropic Properties of Peroxisome Proliferator-Activated Receptors in the Heart: Focus on the Nonmetabolic Effects in Cardiac Protection. Cardiovascular Therapeutics 34:1, pages 37-48.
Crossref
Crossref
Enas A. Abd El-Haleim, Ashraf K. Bahgat & Samira Saleh. (2016) Effects of combined PPAR-γ and PPAR-α agonist therapy on fructose induced NASH in rats: Modulation of gene expression. European Journal of Pharmacology 773, pages 59-70.
Crossref
Crossref
Giuseppe Derosa, Pamela Maffioli & Amirhossein Sahebkar. (2015) Plasma uric acid concentrations are reduced by fenofibrate: A systematic review and meta-analysis of randomized placebo-controlled trials. Pharmacological Research 102, pages 63-70.
Crossref
Crossref
J. Lv, X. Wang, S.Y. Liu, P.F. Liang, M. Feng, L.L. Zhang & A.P. Xu. (2015) Protective effect of Fenofibrate in renal ischemia reperfusion injury: Involved in suppressing kinase 2 (JAK2)/transcription 3 (STAT3)/p53 signaling activation. Pathologie Biologie 63:6, pages 236-242.
Crossref
Crossref
Giuseppe Verdile, Stephanie J. Fuller & Ralph N. Martins. (2015) The role of type 2 diabetes in neurodegeneration. Neurobiology of Disease 84, pages 22-38.
Crossref
Crossref
Cheng Huang, Yang Yang, Wan-Xia Li, Xiao-Qin Wu, Xiao-Feng Li, Tao-Tao Ma, Lei Zhang, Xiao-Ming Meng & Jun Li. (2015) Hyperin attenuates inflammation by activating PPAR-γ in mice with acute liver injury (ALI) and LPS-induced RAW264.7 cells. International Immunopharmacology 29:2, pages 440-447.
Crossref
Crossref
Amirhossein Sahebkar, Luis E. Simental-Mendía, Gianna Ferretti, Tiziana Bacchetti & Jonathan Golledge. (2015) Statin therapy and plasma vitamin E concentrations: A systematic review and meta-analysis of randomized placebo-controlled trials. Atherosclerosis 243:2, pages 579-588.
Crossref
Crossref
Amirhossein Sahebkar, Maria Chantal Ponziani, Ilaria Goitre & Simona Bo. (2015) Does statin therapy reduce plasma VEGF levels in humans? A systematic review and meta-analysis of randomized controlled trials. Metabolism 64:11, pages 1466-1476.
Crossref
Crossref
Daniel M. Craig, Stephen P. Ashcroft, Micah Y. Belew, Ben Stocks, Kevin Currell, Keith Baar & Andrew Philp. (2015) Utilizing small nutrient compounds as enhancers of exercise-induced mitochondrial biogenesis. Frontiers in Physiology 6.
Crossref
Crossref
Gianna Ferretti, Tiziana Bacchetti & Amirhossein Sahebkar. (2015) Effect of statin therapy on paraoxonase-1 status: A systematic review and meta-analysis of 25 clinical trials. Progress in Lipid Research 60, pages 50-73.
Crossref
Crossref
Zhe-Rong Xu, Jin-You Li, Xin-Wei Dong, Zhong-Ju Tan, Wei-Zhen Wu, Qiang-Min Xie & Yun-Mei Yang. (2015) Apple Polyphenols Decrease Atherosclerosis and Hepatic Steatosis in ApoE−/− Mice through the ROS/MAPK/NF-κB Pathway. Nutrients 7:8, pages 7085-7105.
Crossref
Crossref
Peiqiu Cao, Haitao Pan, Tiancun Xiao, Ting Zhou, Jiao Guo & Zhengquan Su. (2015) Advances in the Study of the Antiatherogenic Function and Novel Therapies for HDL. International Journal of Molecular Sciences 16:8, pages 17245-17272.
Crossref
Crossref
Amirhossein Sahebkar, Ali Badiee, Mahdi Hatamipour, Majid Ghayour-Mobarhan & Mahmoud Reza Jaafari. (2015) Apolipoprotein B-100-targeted negatively charged nanoliposomes for the treatment of dyslipidemia. Colloids and Surfaces B: Biointerfaces 129, pages 71-78.
Crossref
Crossref
Amirhossein Sahebkar, Luis E. Simental-Mendía, Gerald F. Watts & Jonathan Golledge. (2015) Impact of fibrate therapy on plasma plasminogen activator inhibitor-1: A systematic review and meta-analysis of randomized controlled trials. Atherosclerosis 240:1, pages 284-296.
Crossref
Crossref
Yuval Ramot, Arianna Mastrofrancesco, Emanuela Camera, Pierre Desreumaux, Ralf Paus & Mauro Picardo. (2015)
The role of PPAR
γ
-mediated signalling in skin biology and pathology: new targets and opportunities for clinical dermatology
. Experimental Dermatology 24:4, pages 245-251.
Crossref
Crossref
Mirjam Schuchardt, Markus Tölle & Markus van der Giet. 2015. High Density Lipoproteins. High Density Lipoproteins
423
453
.
Yahya Dadjo, Yunes Panahi, Bahram Pishgoo, Amirhossein Sahebkar, Hamidreza Taghipour, Ahmad Akbari & Shahram Parvin. (2015)
Effects of Supplementation with
Heracleum persicum
Fruit Extract on Serum Lipids in Patients Undergoing Coronary Angiography: A Pilot Trial
. Phytotherapy Research 29:1, pages 141-143.
Crossref
Crossref
Amirhossein Sahebkar, Gerard T. Chew & Gerald F. Watts. (2014) Recent advances in pharmacotherapy for hypertriglyceridemia. Progress in Lipid Research 56, pages 47-66.
Crossref
Crossref
Yunes Panahi, Nahid Khalili, Mahboobeh Sadat Hosseini, Mohammad Abbasinazari & Amirhossein Sahebkar. (2014) Lipid-modifying effects of adjunctive therapy with curcuminoids?piperine combination in patients with metabolic syndrome: Results of a randomized controlled trial. Complementary Therapies in Medicine 22:5, pages 851-857.
Crossref
Crossref
Amirhossein Sahebkar, Ali Badiee, Majid Ghayour-Mobarhan, Seyed Reza Goldouzian & Mahmoud Reza Jaafari. (2014) A simple and effective approach for the treatment of dyslipidemia using anionic nanoliposomes. Colloids and Surfaces B: Biointerfaces 122, pages 645-652.
Crossref
Crossref
Xiao-Yan Wang, Zhi-Ling Yu, Si-Yuan Pan, Yi Zhang, Nan Sun, Pei-Li Zhu, Zhan-Hong Jia, Shu-Feng Zhou & Kam-Ming Ko. (2014) Supplementation with the Extract of Schisandrae Fructus Pulp, Seed, or Their Combination Influences the Metabolism of Lipids and Glucose in Mice Fed with Normal and Hypercholesterolemic Diet. Evidence-Based Complementary and Alternative Medicine 2014, pages 1-11.
Crossref
Crossref